Financing research and development (R&D) for neglected tropical disease (NTDs) is a big challenge. The problem? Market failure.

Human Hookworm Vaccine Initiative featured in Case Studies for Global Health

Sabin Vaccine’s Human Hookworm Vaccine Initiative (HHVI) is one of 32 projects chosen for inclusion in Case Studies for Global Health released on November 20, 2009 by the Alliance for Case Studies for Global Health. The Alliance is a collaboration of The Bill & Melinda Gates Foundation, World Health Organization's Special Programme for Research and Training in Tropical Diseases (TDR), Global Health Progress (GHP), International AIDS Vaccine Initiative (IAVI) and Association of University Technology Managers (AUTM).

Sabin Vaccine Institute Receives $21.8 Million Grant to Advance Anti-Hookworm Vaccine

WASHINGTON, D.C., June 8, 2005 – The Albert B. Sabin Vaccine Institute, a leader in promoting the development and use of vaccines to prevent disease, today announced that it has received a grant of US$21.8 million from the Bill & Melinda Gates Foundation. The Sabin Vaccine Institute will use this grant—one of the largest awards ever in helminth infection research—to advance its Human Hookworm Vaccine Initiative (HHVI).

Subscribe to RSS - HHVI